| Year |
Citation |
Score |
| 2023 |
Alexander SPH, Mathie AA, Peters JA, Veale EL, Striessnig J, Kelly E, Armstrong JF, Faccenda E, Harding SD, Davies JA, Aldrich RW, Attali B, Baggetta AM, Becirovic E, Biel M, et al. The Concise Guide to PHARMACOLOGY 2023/24: Ion channels. British Journal of Pharmacology. S145-S222. PMID 38123150 DOI: 10.1111/bph.16178 |
0.478 |
|
| 2023 |
Ortner NJ, Sah A, Paradiso E, Shin J, Stojanovic S, Hammer N, Haritonova M, Hofer NT, Marcantoni A, Guarina L, Tuluc P, Theiner T, Pitterl F, Ebner K, Oberacher H, ... ... Striessnig J, et al. The human channel gating-modifying A749G CACNA1D (Cav1.3) variant induces a neurodevelopmental syndrome-like phenotype in mice. Jci Insight. 8. PMID 37698939 DOI: 10.1172/jci.insight.162100 |
0.304 |
|
| 2023 |
Filippini L, Ortner NJ, Kaserer T, Striessnig J. Ca 1.3-selective inhibitors of voltage-gated L-type Ca channels: Fact or (still) fiction? British Journal of Pharmacology. PMID 36788128 DOI: 10.1111/bph.16060 |
0.375 |
|
| 2022 |
Török F, Tezcan K, Filippini L, Fernández-Quintero ML, Zanetti L, Liedl KR, Drexel RS, Striessnig J, Ortner NJ. Germline de novo variant F747S extends the phenotypic spectrum of CACNA1D Ca2+ channelopathies. Human Molecular Genetics. PMID 36208199 DOI: 10.1093/hmg/ddac248 |
0.318 |
|
| 2022 |
Siller A, Hofer NT, Tomagra G, Wiederspohn N, Hess S, Benkert J, Gaifullina A, Spaich D, Duda J, Poetschke C, Vilusic K, Fritz EM, Schneider T, Kloppenburg P, Liss B, ... ... Striessnig J, et al. rβ2-subunit alternative splicing stabilizes Cav2.3 Ca channel activity during continuous midbrain dopamine neuron-like activity. Elife. 11. PMID 35792082 DOI: 10.7554/eLife.67464 |
0.314 |
|
| 2022 |
Shin J, Kovacheva L, Thomas D, Stojanovic S, Knowlton CJ, Mankel J, Boehm J, Farassat N, Paladini C, Striessnig J, Canavier CC, Geisslinger G, Roeper J. Ca1.3 calcium channels are full-range linear amplifiers of firing frequencies in lateral DA SN neurons. Science Advances. 8: eabm4560. PMID 35675413 DOI: 10.1126/sciadv.abm4560 |
0.376 |
|
| 2021 |
Alexander SP, Mathie A, Peters JA, Veale EL, Striessnig J, Kelly E, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Southan C, Davies JA, Aldrich RW, Attali B, Baggetta AM, et al. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Ion channels. British Journal of Pharmacology. 178: S157-S245. PMID 34529831 DOI: 10.1111/bph.15539 |
0.478 |
|
| 2021 |
Striessnig J. Voltage-Gated Ca-Channel α1-Subunit Missense Mutations: Gain or Loss of Function - Implications for Potential Therapies. Frontiers in Synaptic Neuroscience. 13: 634760. PMID 33746731 DOI: 10.3389/fnsyn.2021.634760 |
0.381 |
|
| 2021 |
Hofer NT, Pinggera A, Nikonishyna YV, Tuluc P, Fritz EM, Obermair GJ, Striessnig J. Stabilization of negative activation voltages of Cav1.3 L-Type Ca-channels by alternative splicing. Channels (Austin, Tex.). 15: 38-52. PMID 33380256 DOI: 10.1080/19336950.2020.1859260 |
0.417 |
|
| 2020 |
Ortner NJ, Kaserer T, Copeland JN, Striessnig J. De novo CACAN1D Ca channelopathies: clinical phenotypes and molecular mechanism. Pflugers Archiv : European Journal of Physiology. PMID 32583268 DOI: 10.1007/S00424-020-02418-W |
0.52 |
|
| 2020 |
Hofer NT, Tuluc P, Ortner NJ, Nikonishyna YV, Fernándes-Quintero ML, Liedl KR, Flucher BE, Cox H, Striessnig J. Biophysical classification of a de novo mutation as a high-risk mutation for a severe neurodevelopmental disorder. Molecular Autism. 11: 4. PMID 31921405 DOI: 10.1186/S13229-019-0310-4 |
0.308 |
|
| 2019 |
Ortner NJ, Pinggera A, Hofer NT, Siller A, Brandt N, Raffeiner A, Vilusic K, Lang I, Blum K, Obermair GJ, Stefan E, Engel J, Striessnig J. RBP2 stabilizes slow Cav1.3 Ca channel inactivation properties of cochlear inner hair cells. Pflugers Archiv : European Journal of Physiology. PMID 31848688 DOI: 10.1007/S00424-019-02338-4 |
0.532 |
|
| 2019 |
Alexander SP, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Buneman OP, Cidlowski JA, Christopoulos A, Davenport AP, ... ... Striessnig J, et al. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets. British Journal of Pharmacology. 176: S1-S20. PMID 31710719 DOI: 10.1111/Bph.14747 |
0.353 |
|
| 2019 |
Alexander SP, Mathie A, Peters JA, Veale EL, Striessnig J, Kelly E, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels. British Journal of Pharmacology. 176: S142-S228. PMID 31710715 DOI: 10.1111/Bph.14749 |
0.381 |
|
| 2019 |
Benkert J, Hess S, Roy S, Beccano-Kelly D, Wiederspohn N, Duda J, Simons C, Patil K, Gaifullina A, Mannal N, Dragicevic E, Spaich D, Müller S, Nemeth J, Hollmann H, ... ... Striessnig J, et al. Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson's disease. Nature Communications. 10: 5094. PMID 31704946 DOI: 10.1038/s41467-019-12834-x |
0.301 |
|
| 2019 |
Liss B, Striessnig J. The Potential of L-Type Calcium Channels as a Drug Target for Neuroprotective Therapy in Parkinson's Disease. Annual Review of Pharmacology and Toxicology. 59: 263-289. PMID 30625283 DOI: 10.1146/Annurev-Pharmtox-010818-021214 |
0.308 |
|
| 2019 |
Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J. Voltage-gated calcium channels (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database Iuphar/Bps Guide to Pharmacology Cite. 2019. DOI: 10.2218/gtopdb/f80/2019.4 |
0.637 |
|
| 2019 |
Mesirca P, Mamaeva D, Bidaud I, Davaze R, Difrancesco M, Mitutsova V, Torrente A, Arsic N, Nargeot J, Striessnig J, Lee A, Lamb N, Mangoni M, Fernandez A. Bradycardic mice undergo effective heart rate improvement after specific homing to the sino-atrial node and differentiation of adult muscle derived stem cells Nature Communications. DOI: 10.1101/393512 |
0.414 |
|
| 2018 |
Striessnig J. Getting a handle on Ca2.2 (N-type) voltage-gated Ca channels. Proceedings of the National Academy of Sciences of the United States of America. 115: 12848-12850. PMID 30538200 DOI: 10.1073/Pnas.1818608115 |
0.438 |
|
| 2018 |
Pinggera A, Negro G, Tuluc P, Brown MJ, Lieb A, Striessnig J. Gating defects of disease-causing de novo mutations in Ca1.3 Ca channels. Channels (Austin, Tex.). 12: 388-402. PMID 30465465 DOI: 10.1080/19336950.2018.1546518 |
0.401 |
|
| 2018 |
Ortner NJ, Pinggera A, Siller A, Hofer N, Brandt N, Raffeiner A, Lang I, Stefan E, Obermair GJ, Engel J, Striessnig J. A Complex of RIM2alpha and RIM-Binding Protein 2 Stabilizes Slow Voltage-Dependent Inactivation of Cochlear Inner Hair Cell Cav1.3 L-Type Ca2+ Channels Biophysical Journal. 114: 637a-638a. DOI: 10.1016/J.Bpj.2017.11.3443 |
0.524 |
|
| 2017 |
Alexander SP, Kelly E, Marrion NV, Peters JA, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Buneman OP, Cidlowski JA, Christopoulos A, Davenport AP, Fabbro D, Spedding M, ... Striessnig J, et al. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview. British Journal of Pharmacology. 174: S1-S16. PMID 29055037 DOI: 10.1111/Bph.13882 |
0.418 |
|
| 2017 |
Alexander SP, Striessnig J, Kelly E, Marrion NV, Peters JA, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Voltage-gated ion channels. British Journal of Pharmacology. 174: S160-S194. PMID 29055033 DOI: 10.1111/Bph.13884 |
0.437 |
|
| 2017 |
Monteleone S, Lieb A, Pinggera A, Negro G, Fuchs JE, Hofer F, Striessnig J, Tuluc P, Liedl KR. Mechanisms Responsible for ω-Pore Currents in Cav Calcium Channel Voltage-Sensing Domains. Biophysical Journal. 113: 1485-1495. PMID 28978442 DOI: 10.1016/J.Bpj.2017.08.010 |
0.444 |
|
| 2017 |
Toyoda F, Mesirca P, Dubel S, Ding WG, Striessnig J, Mangoni ME, Matsuura H. CaV1.3 L-type Ca(2+) channel contributes to the heartbeat by generating a dihydropyridine-sensitive persistent Na(+) current. Scientific Reports. 7: 7869. PMID 28801600 DOI: 10.1038/s41598-017-08191-8 |
0.382 |
|
| 2017 |
Pinggera A, Mackenroth L, Rump A, Schallner J, Beleggia F, Wollnik B, Striessnig J. New gain-of-function mutation shows CACNA1D as recurrently mutated gene in autism spectrum disorders and epilepsy. Human Molecular Genetics. PMID 28472301 DOI: 10.1093/Hmg/Ddx175 |
0.475 |
|
| 2017 |
Martínez-Rivera A, Hao J, Tropea TF, Giordano TP, Kosovsky M, Rice RC, Lee A, Huganir RL, Striessnig J, Addy NA, Han S, Rajadhyaksha AM. Enhancing VTA Cav1.3 L-type Ca(2+) channel activity promotes cocaine and mood-related behaviors via overlapping AMPA receptor mechanisms in the nucleus accumbens. Molecular Psychiatry. PMID 28194001 DOI: 10.1038/mp.2017.9 |
0.458 |
|
| 2017 |
Mastrolia V, Flucher SM, Obermair GJ, Drach M, Hofer H, Renström E, Schwartz A, Striessnig J, Flucher BE, Tuluc P. Loss of α2δ-1 Calcium Channel Subunit Function Increases the Susceptibility for Diabetes. Diabetes. PMID 28115397 DOI: 10.2337/Db16-0336 |
0.391 |
|
| 2017 |
Baudot M, Mesirca P, Torrente A, Bidaud I, Roussel J, Laaraoui S, Striessnig J, Shin H, Nargeot J, Barrere-Lemaire S, Mangoni M. P1083Heart automaticity in mice lacking pacemaker L-type Cav1.3 and T-type Cav3.1 channels Ep Europace. 19: iii239-iii240. DOI: 10.1093/ehjci/eux150.006 |
0.305 |
|
| 2017 |
Torrente A, Mesirca P, Bidaud I, Barrere C, Striessnig J, Mangoni M. 55Role of L-type Cav1.3 Ca2+ channels in Ca2+ handling and sinoatrial node pacemaker activity altered by external conditions Ep Europace. 19: iii1-iii1. DOI: 10.1093/ehjci/eux132.001 |
0.369 |
|
| 2017 |
Mesirca P, Bidaud I, Roussel J, Torrente A, Laarioui S, Striessnig J, Engeland B, Isbrandt D, Mangoni M. Concurrent genetic or pharmacologic targeting of L-type Ca 2+ Ca v 1.3 and ‘funny’ f-(HCN) channels eliminates the ‘fight-or-flight’ response in sino-atrial pacemaker activity Archives of Cardiovascular Diseases Supplements. 9: 168-169. DOI: 10.1016/S1878-6480(17)30418-4 |
0.353 |
|
| 2017 |
Baudot M, Mesirca P, Bidaud I, Roussel J, Torrente A, Talssi L, Laarioui S, Shin H, Striessnig J, Barrère-Lemaire S, Mangoni M. Heart automaticity in mice lacking “pacemaker” L-type Ca v 1.3 and Ttype Ca v 3.1 channels Archives of Cardiovascular Diseases Supplements. 9: 168. DOI: 10.1016/S1878-6480(17)30416-0 |
0.356 |
|
| 2017 |
Pinggera A, Mackenroth L, Striessnig J. Ca V 1.3 ( Cacna1d ) Gain-of-Function De Novo Missense Mutations are Associated with CNS Disorders Biophysical Journal. 112: 109a. DOI: 10.1016/J.Bpj.2016.11.616 |
0.309 |
|
| 2016 |
Striessnig J. Voltage-gated calcium channels - from basic mechanisms to disease. The Journal of Physiology. 594: 5817-5821. PMID 27739079 DOI: 10.1113/Jp272619 |
0.521 |
|
| 2016 |
Stanika R, Campiglio M, Pinggera A, Lee A, Striessnig J, Flucher BE, Obermair GJ. Splice variants of the CaV1.3 L-type calcium channel regulate dendritic spine morphology. Scientific Reports. 6: 34528. PMID 27708393 DOI: 10.1038/Srep34528 |
0.556 |
|
| 2016 |
Pinggera A, Striessnig J. Cav 1.3 (CACNA1D) L-type Ca(2+) channel dysfunction in CNS disorders. The Journal of Physiology. PMID 26842699 DOI: 10.1113/Jp270672 |
0.4 |
|
| 2016 |
Mesirca P, Bidaud I, Briec F, Evain S, Torrente AG, Le Quang K, Leoni AL, Baudot M, Marger L, Chung You Chong A, Nargeot J, Striessnig J, Wickman K, Charpentier F, Mangoni ME. G protein-gated IKACh channels as therapeutic targets for treatment of sick sinus syndrome and heart block. Proceedings of the National Academy of Sciences of the United States of America. PMID 26831068 DOI: 10.1073/Pnas.1517181113 |
0.305 |
|
| 2016 |
Torrente AG, Mesirca P, Neco P, Rizzetto R, Dubel S, Barrere C, Sinegger-Brauns M, Striessnig J, Richard S, Nargeot J, Gomez AM, Mangoni ME. L-type Cav1.3 Channels Regulate Ryanodine Receptor-dependent Ca2+ Release during Sino-Atrial Node Pacemaker Activity. Cardiovascular Research. PMID 26786159 DOI: 10.1093/cvr/cvw006 |
0.391 |
|
| 2015 |
Marschallinger J, Sah A, Schmuckermair C, Unger M, Rotheneichner P, Kharitonova M, Waclawiczek A, Gerner P, Jaksch-Bogensperger H, Berger S, Striessnig J, Singewald N, Couillard-Despres S, Aigner L. The L-type calcium channel Cav1.3 is required for proper hippocampal neurogenesis and cognitive functions. Cell Calcium. PMID 26459417 DOI: 10.1016/J.Ceca.2015.09.007 |
0.344 |
|
| 2015 |
Poetschke C, Dragicevic E, Duda J, Benkert J, Dougalis A, DeZio R, Snutch TP, Striessnig J, Liss B. Compensatory T-type Ca(2+) channel activity alters D2-autoreceptor responses of Substantia nigra dopamine neurons from Cav1.3 L-type Ca(2+) channel KO mice. Scientific Reports. 5: 13688. PMID 26381090 DOI: 10.1038/Srep13688 |
0.326 |
|
| 2015 |
Scharinger A, Eckrich S, Vandael DH, Schönig K, Koschak A, Hecker D, Kaur G, Lee A, Sah A, Bartsch D, Benedetti B, Lieb A, Schick B, Singewald N, Sinnegger-Brauns MJ, ... ... Striessnig J, et al. Cell-type-specific tuning of Cav1.3 Ca(2+)-channels by a C-terminal automodulatory domain. Frontiers in Cellular Neuroscience. 9: 309. PMID 26379493 DOI: 10.3389/Fncel.2015.00309 |
0.663 |
|
| 2015 |
Zamponi GW, Striessnig J, Koschak A, Dolphin AC. The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential. Pharmacological Reviews. 67: 821-70. PMID 26362469 DOI: 10.1124/Pr.114.009654 |
0.464 |
|
| 2015 |
Kaur G, Pinggera A, Ortner NJ, Lieb A, Sinnegger-Brauns MJ, Yarov-Yarovoy V, Obermair GJ, Flucher BE, Striessnig J. A Polybasic Plasma Membrane Binding Motif in the I-II Linker Stabilizes Voltage-gated CaV1.2 Calcium Channel Function. The Journal of Biological Chemistry. 290: 21086-100. PMID 26100638 DOI: 10.1074/Jbc.M115.645671 |
0.526 |
|
| 2015 |
Ortner NJ, Striessnig J. L-type calcium channels as drug targets in CNS disorders. Channels (Austin, Tex.). 1-7. PMID 26039257 DOI: 10.1080/19336950.2015.1048936 |
0.519 |
|
| 2015 |
Striessnig J, Ortner NJ, Pinggera A. Pharmacology of L-type Calcium Channels: Novel Drugs for Old Targets? Current Molecular Pharmacology. 8: 110-22. PMID 25966690 DOI: 10.2174/1874467208666150507105845 |
0.51 |
|
| 2015 |
Pinggera A, Lieb A, Benedetti B, Lampert M, Monteleone S, Liedl KR, Tuluc P, Striessnig J. CACNA1D de novo mutations in autism spectrum disorders activate Cav1.3 L-type calcium channels. Biological Psychiatry. 77: 816-22. PMID 25620733 DOI: 10.1016/J.Biopsych.2014.11.020 |
0.399 |
|
| 2015 |
Yang G, Shi Y, Yu J, Li Y, Yu L, Welling A, Hofmann F, Striessnig J, Juntti-Berggren L, Berggren PO, Yang SN. CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum. Cellular and Molecular Life Sciences : Cmls. 72: 1197-207. PMID 25292336 DOI: 10.1007/S00018-014-1737-6 |
0.47 |
|
| 2015 |
Scharinger A, Eckrich S, Vandael DH, Schönig K, Koschak A, Hecker D, Kaur G, Lee A, Sah A, Bartsch D, Benedetti B, Lieb A, Schick B, Singewald N, Sinnegger-Brauns MJ, ... ... Striessnig J, et al. Cell-type-specific tuning of Cav1.3 Ca2+-channels by a C-terminal automodulatory domain Frontiers in Cellular Neuroscience. 9. DOI: 10.3389/fncel.2015.00309 |
0.39 |
|
| 2015 |
Viviana D, Covinhes A, Mesirca P, Bidaud I, Nargeot J, Piot C, Striessnig J, Mangoni M, Barrère-Lemaire S. 0374 : Cardioprotection against ischemia-reperfusion injury by heart rate control Archives of Cardiovascular Diseases Supplements. 7: 151. DOI: 10.1016/S1878-6480(15)30057-4 |
0.314 |
|
| 2014 |
Ortner NJ, Bock G, Vandael DH, Mauersberger R, Draheim HJ, Gust R, Carbone E, Tuluc P, Striessnig J. Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators. Nature Communications. 5: 3897. PMID 24941892 DOI: 10.1038/Ncomms4897 |
0.566 |
|
| 2014 |
Liu Y, Harding M, Pittman A, Dore J, Striessnig J, Rajadhyaksha A, Chen X. Cav1.2 and Cav1.3 L-type calcium channels regulate dopaminergic firing activity in the mouse ventral tegmental area. Journal of Neurophysiology. 112: 1119-30. PMID 24848473 DOI: 10.1152/Jn.00757.2013 |
0.457 |
|
| 2014 |
Lieb A, Ortner N, Striessnig J. C-terminal modulatory domain controls coupling of voltage-sensing to pore opening in Cav1.3 L-type Ca(2+) channels. Biophysical Journal. 106: 1467-75. PMID 24703308 DOI: 10.1016/J.Bpj.2014.02.017 |
0.43 |
|
| 2014 |
Striessnig J, Pinggera A, Kaur G, Bock G, Tuluc P. L-type Ca(2+) channels in heart and brain. Wiley Interdisciplinary Reviews. Membrane Transport and Signaling. 3: 15-38. PMID 24683526 DOI: 10.1002/wmts.102 |
0.482 |
|
| 2014 |
Betancourt VD, Covihnes A, Mesirca P, Bidaud I, Nargeot J, Piot C, Striessnig J, Mangoni M, Barrere-Lemaire S. P666Heart rate control protects against ischemia-reperfusion injury Cardiovascular Research. 103. DOI: 10.1093/Cvr/Cvu098.91 |
0.336 |
|
| 2014 |
Betancourt VD, Mesirca P, Covinhes A, Bidaud I, Nargeot J, Piot C, Striessnig J, Mangoni M, Barrère-Lemaire S. 0324: Cardioprotection against ischemia-reperfusion injury by heart rate control Archives of Cardiovascular Diseases Supplements. 6: 30-31. DOI: 10.1016/S1878-6480(14)71347-3 |
0.323 |
|
| 2014 |
Lieb A, Ortner N, Pinggera A, Azizan EA, Brown MJ, Tuluc P, Striessnig J. Gating Properties of Cav1.3 Calcium Channels: Insight from Alternative Splicing and Human Mutations Biophysical Journal. 106: 134a. DOI: 10.1016/J.Bpj.2013.11.788 |
0.496 |
|
| 2014 |
Burtscher V, Knoflach D, Kugler C, Scharinger A, Glösmann M, Blatsios G, Janecke A, Striessnig J, Obermair GJ, Schicker KW, Koschak A. Is There a Contribution of Both Cav1.4 and Cav1.3 L-Type Calcium Channels to Retinal Synaptic Transmission? Biophysical Journal. 106: 332a. DOI: 10.1016/J.Bpj.2013.11.1906 |
0.459 |
|
| 2014 |
Tuluc P, Mastrolia V, Drach M, Flucher SM, Renström E, Striessnig J, Flucher BE. Calcium Channel α2δ-1 Subunit Knockout Causes Diabetes Due to Impaired Insulin Release Biophysical Journal. 106: 331a. DOI: 10.1016/J.Bpj.2013.11.1902 |
0.341 |
|
| 2014 |
Eckrich S, Scharinger A, Muenkner S, Schönig K, Lee A, Bartsch D, Koschak A, Sinnegger-Brauns M, Hecker D, Schick B, Striessnig J, Engel J. C-Terminal Modulation of Cav1.3 L-Type Calcium Channels Modifies their Gating Properties in Cochlear Inner Hair Cells Biophysical Journal. 106: 329a. DOI: 10.1016/j.bpj.2013.11.1893 |
0.619 |
|
| 2014 |
Striessnig J. Cav1.3 L-Type Calcium Channel Dysfunction in Human Disease Biophysical Journal. 106: 220a. DOI: 10.1016/J.Bpj.2013.11.1287 |
0.521 |
|
| 2014 |
Koschak A, Pinggera A, Schicker K, Striessnig J. Role of L-type Ca2+ channels in sensory cells Pathologies of Calcium Channels. 47-75. DOI: 10.1007/978-3-642-40282-1_3 |
0.414 |
|
| 2013 |
Striessnig J. Lonely but diverse: Cav1.3 L-type Ca(2+) channels in cochlear inner hair cells. Channels (Austin, Tex.). 7: 133-4. PMID 23567254 DOI: 10.4161/Chan.24457 |
0.561 |
|
| 2013 |
Scharinger A, Schönig K, Bartsch D, Kaur G, Gebhart M, Sah A, Singewald N, Lee A, Koschak A, Sinnegger-Brauns MJ, Striessnig J. A Novel Animal Model to Study the In Vivo Role of a C-Terminal Regulatory Domain in Cav1.3 L-Type Calcium Channels Biophysical Journal. 104: 459a. DOI: 10.1016/j.bpj.2012.11.2539 |
0.522 |
|
| 2012 |
Vandael DH, Zuccotti A, Striessnig J, Carbone E. Ca(V)1.3-driven SK channel activation regulates pacemaking and spike frequency adaptation in mouse chromaffin cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 16345-59. PMID 23152617 DOI: 10.1523/Jneurosci.3715-12.2012 |
0.407 |
|
| 2012 |
Christel CJ, Cardona N, Mesirca P, Herrmann S, Hofmann F, Striessnig J, Ludwig A, Mangoni ME, Lee A. Distinct localization and modulation of Cav1.2 and Cav1.3 L-type Ca2+ channels in mouse sinoatrial node. The Journal of Physiology. 590: 6327-42. PMID 23045342 DOI: 10.1113/jphysiol.2012.239954 |
0.531 |
|
| 2012 |
Lieb A, Scharinger A, Sartori S, Sinnegger-Brauns MJ, Striessnig J. Structural determinants of CaV1.3 L-type calcium channel gating. Channels (Austin, Tex.). 6: 197-205. PMID 22760075 DOI: 10.4161/Chan.21002 |
0.431 |
|
| 2012 |
JurkoviÄová-Tarabová B, Griesemer D, Pirone A, Sinnegger-Brauns MJ, Striessnig J, Friauf E. Repertoire of high voltage-activated Ca2+ channels in the lateral superior olive: functional analysis in wild-type, Ca(v)1.3(-/-), and Ca(v)1.2DHP(-/-) mice. Journal of Neurophysiology. 108: 365-79. PMID 22539826 DOI: 10.1152/jn.00948.2011 |
0.364 |
|
| 2012 |
Scharinger A, Hechenblaikner F, Bock G, Gebhart M, Schönig K, Bartsch D, Sah A, Singewald N, Sinnegger-Brauns MJ, Striessnig J. A mouse model to study the C-terminal regulation of CaV1.3 L-type calcium channels Bmc Pharmacology and Toxicology. 13. DOI: 10.1186/2050-6511-13-S1-A50 |
0.553 |
|
| 2012 |
Pinggera A, Brandt N, Kaur G, Engel J, Striessnig J. Regulation of CaV1.3 Ca2+channels in cochlear inner hair cells Bmc Pharmacology and Toxicology. 13. DOI: 10.1186/2050-6511-13-S1-A49 |
0.581 |
|
| 2011 |
Bock G, Gebhart M, Scharinger A, Jangsangthong W, Busquet P, Poggiani C, Sartori S, Mangoni ME, Sinnegger-Brauns MJ, Herzig S, Striessnig J, Koschak A. Functional properties of a newly identified C-terminal splice variant of Cav1.3 L-type Ca2+ channels. The Journal of Biological Chemistry. 286: 42736-48. PMID 21998310 DOI: 10.1074/Jbc.M111.269951 |
0.487 |
|
| 2011 |
Rose RA, Sellan M, Simpson JA, Izaddoustdar F, Cifelli C, Panama BK, Davis M, Zhao D, Markhani M, Murphy GG, Striessnig J, Liu PP, Heximer SP, Backx PH. Iron overload decreases CaV1.3-dependent L-type Ca2+ currents leading to bradycardia, altered electrical conduction, and atrial fibrillation. Circulation. Arrhythmia and Electrophysiology. 4: 733-42. PMID 21747058 DOI: 10.1161/Circep.110.960401 |
0.305 |
|
| 2011 |
Hirtz JJ, Boesen M, Braun N, Deitmer JW, Kramer F, Lohr C, Müller B, Nothwang HG, Striessnig J, Löhrke S, Friauf E. Cav1.3 calcium channels are required for normal development of the auditory brainstem. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 8280-94. PMID 21632949 DOI: 10.1523/Jneurosci.5098-10.2011 |
0.477 |
|
| 2011 |
Mahapatra S, Marcantoni A, Vandael DH, Striessnig J, Carbone E. Are Ca(v)1.3 pacemaker channels in chromaffin cells? Possible bias from resting cell conditions and DHP blockers usage. Channels (Austin, Tex.). 5: 219-24. PMID 21406973 DOI: 10.4161/Chan.5.3.15271 |
0.449 |
|
| 2011 |
Marger L, Mesirca P, Alig J, Torrente A, Dubel S, Engeland B, Kanani S, Fontanaud P, Striessnig J, Shin HS, Isbrandt D, Ehmke H, Nargeot J, Mangoni ME. Functional roles of Ca(v)1.3, Ca(v)3.1 and HCN channels in automaticity of mouse atrioventricular cells: insights into the atrioventricular pacemaker mechanism. Channels (Austin, Tex.). 5: 251-61. PMID 21406960 DOI: 10.4161/Chan.5.3.15266 |
0.499 |
|
| 2011 |
Marger L, Mesirca P, Alig J, Torrente A, Dubel S, Engeland B, Kanani S, Fontanaud P, Striessnig J, Shin HS, Isbrandt D, Ehmke H, Nargeot J, Mangoni ME. Pacemaker activity and ionic currents in mouse atrioventricular node cells. Channels (Austin, Tex.). 5: 241-50. PMID 21406959 DOI: 10.4161/Chan.5.3.15264 |
0.369 |
|
| 2011 |
Baig SM, Koschak A, Lieb A, Gebhart M, Dafinger C, Nürnberg G, Ali A, Ahmad I, Sinnegger-Brauns MJ, Brandt N, Engel J, Mangoni ME, Farooq M, Khan HU, Nürnberg P, ... Striessnig J, et al. Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness. Nature Neuroscience. 14: 77-84. PMID 21131953 DOI: 10.1038/Nn.2694 |
0.515 |
|
| 2011 |
Juhasz-Vedres G, Scharinger A, Gebhart M, Busquet P, Poggiani C, Sartori SB, Sinnegger-Brauns MJ, Koschak A, Striessnig J. Identification of a new C-terminal splice variant of CaV1.3 L-type calcium channels with unique functional properties Bmc Pharmacology. 11: A44. DOI: 10.1186/1471-2210-11-S2-A44 |
0.519 |
|
| 2011 |
Lieb A, Baig SM, Gebhart M, Dafinger C, Engel J, Sinnegger-Brauns MJ, Mangoni ME, Khan HU, Nürnberg P, Bolz HJ, Koschak A, Striessnig J. Biophysical Properties of a Human Disease-Causing Mutation in CaV1.3 L-Type Calcium Channels Biophysical Journal. 100: 570a. DOI: 10.1016/J.Bpj.2010.12.3301 |
0.516 |
|
| 2011 |
Marger L, Mesirca P, Alig J, Torrente A, Dubel S, Engeland B, Kanani S, Fontanaud P, Striessnig J, Shin HS, Isbrandt D, Ehmke H, Nargeot J, Mangoni ME. Functional roles of Cav1.3, Cav3.1 and HCN channels in automaticity of mouse atrioventricular cells: Insights into the atrioventricular pacemaker mechanism Channels. 5. |
0.362 |
|
| 2011 |
Mahapatra S, Marcantoni A, Vandael DHF, Striessnig J, Carbone E. Are Ca v1.3 pacemaker channels in chromaffin cells? Possible bias from resting cell conditions and DHP blocker usage Channels. 5. |
0.379 |
|
| 2010 |
Giordano TP, Tropea TF, Satpute SS, Sinnegger-Brauns MJ, Striessnig J, Kosofsky BE, Rajadhyaksha AM. Molecular switch from L-type Ca v 1.3 to Ca v 1.2 Ca2+ channel signaling underlies long-term psychostimulant-induced behavioral and molecular plasticity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 17051-62. PMID 21159975 DOI: 10.1523/Jneurosci.2255-10.2010 |
0.311 |
|
| 2010 |
Müller CS, Haupt A, Bildl W, Schindler J, Knaus HG, Meissner M, Rammner B, Striessnig J, Flockerzi V, Fakler B, Schulte U. Quantitative proteomics of the Cav2 channel nano-environments in the mammalian brain. Proceedings of the National Academy of Sciences of the United States of America. 107: 14950-7. PMID 20668236 DOI: 10.1073/Pnas.1005940107 |
0.546 |
|
| 2010 |
Gebhart M, Juhasz-Vedres G, Zuccotti A, Brandt N, Engel J, Trockenbacher A, Kaur G, Obermair GJ, Knipper M, Koschak A, Striessnig J. Modulation of Cav1.3 Ca2+ channel gating by Rab3 interacting molecule. Molecular and Cellular Neurosciences. 44: 246-59. PMID 20363327 DOI: 10.1016/J.Mcn.2010.03.011 |
0.525 |
|
| 2010 |
Striessnig J, Bolz HJ, Koschak A. Channelopathies in Cav1.1, Cav1.3, and Cav1.4 voltage-gated L-type Ca2+ channels. Pflã¼Gers Archiv : European Journal of Physiology. 460: 361-74. PMID 20213496 DOI: 10.1007/S00424-010-0800-X |
0.554 |
|
| 2010 |
Marcantoni A, Vandael DH, Mahapatra S, Carabelli V, Sinnegger-Brauns MJ, Striessnig J, Carbone E. Loss of Cav1.3 channels reveals the critical role of L-type and BK channel coupling in pacemaking mouse adrenal chromaffin cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 491-504. PMID 20071512 DOI: 10.1523/Jneurosci.4961-09.2010 |
0.464 |
|
| 2010 |
Busquet P, Nguyen NK, Schmid E, Tanimoto N, Seeliger MW, Ben-Yosef T, Mizuno F, Akopian A, Striessnig J, Singewald N. CaV1.3 L-type Ca2+ channels modulate depression-like behaviour in mice independent of deaf phenotype. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 499-513. PMID 19664321 DOI: 10.1017/S1461145709990368 |
0.47 |
|
| 2010 |
Juhasz-Vedres G, Hechenblaikner F, Lieb A, Gebhart M, Cimerman J, Sinnegger-Brauns M, Striessnig J, Koschak A. Molecular Basis of a C Terminal Modulatory Mechanism in Cav1.3 Voltage-Gated Ca2+ Channels Biophysical Journal. 98: 693a-694a. DOI: 10.1016/j.bpj.2009.12.3809 |
0.41 |
|
| 2010 |
Mesirca P, Marger L, Torrente A, Striessnig J, Nargeot J, Mangoni ME. Pacemaker Cells of the Atrioventricular Node are CaV1.3 Dependent Oscillators Biophysical Journal. 98. DOI: 10.1016/J.Bpj.2009.12.1837 |
0.501 |
|
| 2009 |
Striessnig J. An oily competition: role of beta subunit palmitoylation for Ca2+ channel modulation by fatty acids. The Journal of General Physiology. 134: 363-7. PMID 19858356 DOI: 10.1085/Jgp.200910330 |
0.496 |
|
| 2009 |
Subramanyam P, Obermair GJ, Baumgartner S, Gebhart M, Striessnig J, Kaufmann WA, Geley S, Flucher BE. Activity and calcium regulate nuclear targeting of the calcium channel beta4b subunit in nerve and muscle cells. Channels (Austin, Tex.). 3: 343-55. PMID 19755859 DOI: 10.4161/Chan.3.5.9696 |
0.386 |
|
| 2009 |
Zhang E, Reinbothe T, Andersson SA, Eliasson L, Brauns M, Striessnig J, Renström E. Rapid changes in surface expression of L-type Cav1.2 channels in stimulated INS-1 cells Diabetologia. 52: 436-436. PMID 19685092 DOI: 10.1007/S00125-009-1445-1 |
0.425 |
|
| 2009 |
Horak S, Koschak A, Stuppner H, Striessnig J. Use-dependent block of voltage-gated Cav2.1 Ca2+ channels by petasins and eudesmol isomers. The Journal of Pharmacology and Experimental Therapeutics. 330: 220-6. PMID 19369579 DOI: 10.1124/jpet.109.151183 |
0.428 |
|
| 2009 |
Bova S, Saponara S, Rampa A, Gobbi S, Cima L, Fusi F, Sgaragli G, Cavalli M, de los Rios C, Striessnig J, Bisi A. Anthracene based compounds as new L-type Ca2+ channel blockers: design, synthesis, and full biological profile. Journal of Medicinal Chemistry. 52: 1259-62. PMID 19203272 DOI: 10.1021/Jm801589X |
0.566 |
|
| 2009 |
Sinnegger-Brauns MJ, Huber IG, Koschak A, Wild C, Obermair GJ, Einzinger U, Hoda JC, Sartori SB, Striessnig J. Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms. Molecular Pharmacology. 75: 407-14. PMID 19029287 DOI: 10.1124/mol.108.049981 |
0.371 |
|
| 2009 |
Busquet P, Nguyen NK, Schmid E, Tanimoto N, Seeliger MW, Ben-Yosef T, Mizuno F, Akopian A, Singewald N, Striessnig J. CaV1.3 L-type calcium channels modulate depression-like behavior in mice independent of deaf phenotype Bmc Pharmacology. 9: 1-2. DOI: 10.1186/1471-2210-9-S2-A21 |
0.427 |
|
| 2009 |
Subramanyam P, Obermair GJ, Baumgartner S, Gebhart M, Striessnig J, Kaufmann WA, Geley S, Flucher BE. Activity and calcium regulate nuclear targeting of the calcium channel β4b subunit in nerve and muscle cells Channels. 3. |
0.33 |
|
| 2008 |
Watschinger K, Horak SB, Schulze K, Obermair GJ, Wild C, Koschak A, Sinnegger-Brauns MJ, Tampé R, Striessnig J. Functional properties and modulation of extracellular epitope-tagged Ca(V)2.1 voltage-gated calcium channels. Channels (Austin, Tex.). 2: 461-73. PMID 18797193 DOI: 10.4161/Chan.2.6.6793 |
0.571 |
|
| 2008 |
Striessnig J, Koschak A. Exploring the function and pharmacotherapeutic potential of voltage-gated Ca2+ channels with gene knockout models. Channels (Austin, Tex.). 2: 233-51. PMID 18719397 DOI: 10.4161/Chan.2.4.5847 |
0.559 |
|
| 2008 |
Singh A, Gebhart M, Fritsch R, Sinnegger-Brauns MJ, Poggiani C, Hoda JC, Engel J, Romanin C, Striessnig J, Koschak A. Modulation of voltage- and Ca2+-dependent gating of CaV1.3 L-type calcium channels by alternative splicing of a C-terminal regulatory domain. The Journal of Biological Chemistry. 283: 20733-44. PMID 18482979 DOI: 10.1074/Jbc.M802254200 |
0.526 |
|
| 2008 |
Busquet P, Hetzenauer A, Sinnegger-Brauns MJ, Striessnig J, Singewald N. Role of L-type Ca2+ channel isoforms in the extinction of conditioned fear. Learning & Memory (Cold Spring Harbor, N.Y.). 15: 378-86. PMID 18441296 DOI: 10.1101/Lm.886208 |
0.417 |
|
| 2008 |
Mezghrani A, Monteil A, Watschinger K, Sinnegger-Brauns MJ, Barrère C, Bourinet E, Nargeot J, Striessnig J, Lory P. A destructive interaction mechanism accounts for dominant-negative effects of misfolded mutants of voltage-gated calcium channels. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 4501-11. PMID 18434528 DOI: 10.1523/Jneurosci.2844-07.2008 |
0.554 |
|
| 2008 |
Hendrich J, Van Minh AT, Heblich F, Nieto-Rostro M, Watschinger K, Striessnig J, Wratten J, Davies A, Dolphin AC. Pharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentin. Proceedings of the National Academy of Sciences of the United States of America. 105: 3628-33. PMID 18299583 DOI: 10.1073/pnas.0708930105 |
0.371 |
|
| 2008 |
Gebhart M, Juhasz-Vedres G, Trockenbacher A, Obermair GJ, Engel J, Koschak A, Striessnig J. RIM modulates CaV1.3 Ca2+ channels Bmc Pharmacology. 8: A22. DOI: 10.1186/1471-2210-8-S1-A22 |
0.517 |
|
| 2007 |
Striessnig J. C-terminal tailoring of L-type calcium channel function. The Journal of Physiology. 585: 643-4. PMID 18084049 DOI: 10.1113/Jphysiol.2007.147140 |
0.502 |
|
| 2007 |
Navedo MF, Amberg GC, Westenbroek RE, Sinnegger-Brauns MJ, Catterall WA, Striessnig J, Santana LF. Ca(v)1.3 channels produce persistent calcium sparklets, but Ca(v)1.2 channels are responsible for sparklets in mouse arterial smooth muscle. American Journal of Physiology. Heart and Circulatory Physiology. 293: H1359-70. PMID 17526649 DOI: 10.1152/Ajpheart.00450.2007 |
0.622 |
|
| 2007 |
Koschak A, Obermair GJ, Pivotto F, Sinnegger-Brauns MJ, Striessnig J, Pietrobon D. Molecular nature of anomalous L-type calcium channels in mouse cerebellar granule cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 3855-63. PMID 17409250 DOI: 10.1523/Jneurosci.4028-06.2007 |
0.506 |
|
| 2007 |
Wu J, Marmorstein AD, Striessnig J, Peachey NS. Voltage-dependent calcium channel CaV1.3 subunits regulate the light peak of the electroretinogram. Journal of Neurophysiology. 97: 3731-5. PMID 17376851 DOI: 10.1152/Jn.00146.2007 |
0.331 |
|
| 2007 |
Erazo-Fischer E, Striessnig J, Taschenberger H. The role of physiological afferent nerve activity during in vivo maturation of the calyx of Held synapse. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 1725-37. PMID 17301180 DOI: 10.1523/Jneurosci.4116-06.2007 |
0.366 |
|
| 2007 |
Singh A, Gebhart M, Fritsch R, Hoda J, Sinnegger-Brauns M, Romanin C, Striessnig J, Koschak A. C-terminal splicing reveals intramolecular gating modulation in CaV1.3 L-type Ca2+ channels Bmc Pharmacology. 7: A11. DOI: 10.1186/1471-2210-7-S2-A11 |
0.53 |
|
| 2006 |
Striessnig J, Koschak A, Sinnegger-Brauns MJ, Hetzenauer A, Nguyen NK, Busquet P, Pelster G, Singewald N. Role of voltage-gated L-type Ca2+ channel isoforms for brain function. Biochemical Society Transactions. 34: 903-9. PMID 17052224 DOI: 10.1042/Bst0340903 |
0.475 |
|
| 2006 |
Singh A, Hamedinger D, Hoda JC, Gebhart M, Koschak A, Romanin C, Striessnig J. C-terminal modulator controls Ca2+-dependent gating of Ca(v)1.4 L-type Ca2+ channels. Nature Neuroscience. 9: 1108-16. PMID 16921373 DOI: 10.1038/Nn1751 |
0.53 |
|
| 2006 |
Hetzenauer A, Sinnegger-Brauns MJ, Striessnig J, Singewald N. Brain activation pattern induced by stimulation of L-type Ca2+-channels: contribution of Ca(V)1.3 and Ca(V)1.2 isoforms. Neuroscience. 139: 1005-15. PMID 16542784 DOI: 10.1016/J.Neuroscience.2006.01.059 |
0.507 |
|
| 2006 |
Hoda JC, Zaghetto F, Singh A, Koschak A, Striessnig J. Effects of congenital stationary night blindness type 2 mutations R508Q and L1364H on Cav1.4 L-type Ca2+ channel function and expression. Journal of Neurochemistry. 96: 1648-58. PMID 16476079 DOI: 10.1111/J.1471-4159.2006.03678.X |
0.506 |
|
| 2006 |
Mangoni ME, Couette B, Marger L, Bourinet E, Striessnig J, Nargeot J. Voltage-dependent calcium channels and cardiac pacemaker activity: from ionic currents to genes. Progress in Biophysics and Molecular Biology. 90: 38-63. PMID 15979127 DOI: 10.1016/J.Pbiomolbio.2005.05.003 |
0.511 |
|
| 2005 |
Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J. International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacological Reviews. 57: 411-25. PMID 16382099 DOI: 10.1124/Pr.57.4.5 |
0.572 |
|
| 2005 |
Hemara-Wahanui A, Berjukow S, Hope CI, Dearden PK, Wu SB, Wilson-Wheeler J, Sharp DM, Lundon-Treweek P, Clover GM, Hoda JC, Striessnig J, Marksteiner R, Hering S, Maw MA. A CACNA1F mutation identified in an X-linked retinal disorder shifts the voltage dependence of Cav1.4 channel activation. Proceedings of the National Academy of Sciences of the United States of America. 102: 7553-8. PMID 15897456 DOI: 10.1073/pnas.0501907102 |
0.455 |
|
| 2005 |
Hoda JC, Zaghetto F, Koschak A, Striessnig J. Congenital stationary night blindness type 2 mutations S229P, G369D, L1068P, and W1440X alter channel gating or functional expression of Ca(v)1.4 L-type Ca2+ channels. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 252-9. PMID 15634789 DOI: 10.1523/Jneurosci.3054-04.2005 |
0.532 |
|
| 2004 |
Huber IG, Wappl-Kornherr E, Sinnegger-Brauns MJ, Hoda JC, Walter-Bastl D, Striessnig J. Opposite effects of a single IIIS5 mutation on phenylalkylamine and dihydropyridine interaction with L-type Ca2+ channels. The Journal of Biological Chemistry. 279: 55211-7. PMID 15504730 DOI: 10.1074/Jbc.M409008200 |
0.584 |
|
| 2004 |
Müllner C, Broos LA, van den Maagdenberg AM, Striessnig J. Familial hemiplegic migraine type 1 mutations K1336E, W1684R, and V1696I alter Cav2.1 Ca2+ channel gating: evidence for beta-subunit isoform-specific effects. The Journal of Biological Chemistry. 279: 51844-50. PMID 15448138 DOI: 10.1074/Jbc.M408756200 |
0.423 |
|
| 2004 |
Striessnig J, Hoda JC, Koschak A, Zaghetto F, Müllner C, Sinnegger-Brauns MJ, Wild C, Watschinger K, Trockenbacher A, Pelster G. L-type Ca2+ channels in Ca2+ channelopathies. Biochemical and Biophysical Research Communications. 322: 1341-6. PMID 15336981 DOI: 10.1016/J.Bbrc.2004.08.039 |
0.504 |
|
| 2004 |
Kugler G, Grabner M, Platzer J, Striessnig J, Flucher BE. The monoclonal antibody mAB 1A binds to the excitation--contraction coupling domain in the II-III loop of the skeletal muscle calcium channel alpha(1S) subunit. Archives of Biochemistry and Biophysics. 427: 91-100. PMID 15178491 DOI: 10.1016/J.Abb.2004.04.007 |
0.435 |
|
| 2004 |
Matthes J, Yildirim L, Wietzorrek G, Reimer D, Striessnig J, Herzig S. Disturbed atrio-ventricular conduction and normal contractile function in isolated hearts from Cav1.3-knockout mice. Naunyn-Schmiedeberg's Archives of Pharmacology. 369: 554-62. PMID 15146309 DOI: 10.1007/S00210-004-0940-7 |
0.349 |
|
| 2003 |
Catterall WA, Striessnig J, Snutch TP, Perez-Reyes E. International Union of Pharmacology. XL. Compendium of voltage-gated ion channels: calcium channels. Pharmacological Reviews. 55: 579-81. PMID 14657414 DOI: 10.1124/Pr.55.4.8 |
0.581 |
|
| 2003 |
Brandt A, Striessnig J, Moser T. CaV1.3 channels are essential for development and presynaptic activity of cochlear inner hair cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 10832-40. PMID 14645476 DOI: 10.1523/Jneurosci.23-34-10832.2003 |
0.432 |
|
| 2003 |
Michna M, Knirsch M, Hoda JC, Muenkner S, Langer P, Platzer J, Striessnig J, Engel J. Cav1.3 (alpha1D) Ca2+ currents in neonatal outer hair cells of mice. The Journal of Physiology. 553: 747-58. PMID 14514878 DOI: 10.1113/Jphysiol.2003.053256 |
0.447 |
|
| 2003 |
Wolf M, Eberhart A, Glossmann H, Striessnig J, Grigorieff N. Visualization of the domain structure of an L-type Ca2+ channel using electron cryo-microscopy. Journal of Molecular Biology. 332: 171-82. PMID 12946355 DOI: 10.1016/S0022-2836(03)00899-4 |
0.656 |
|
| 2003 |
Clark NC, Nagano N, Kuenzi FM, Jarolimek W, Huber I, Walter D, Wietzorrek G, Boyce S, Kullmann DM, Striessnig J, Seabrook GR. Neurological phenotype and synaptic function in mice lacking the CaV1.3 alpha subunit of neuronal L-type voltage-dependent Ca2+ channels. Neuroscience. 120: 435-42. PMID 12890513 DOI: 10.1016/S0306-4522(03)00329-4 |
0.473 |
|
| 2003 |
Koschak A, Reimer D, Walter D, Hoda JC, Heinzle T, Grabner M, Striessnig J. Cav1.4alpha1 subunits can form slowly inactivating dihydropyridine-sensitive L-type Ca2+ channels lacking Ca2+-dependent inactivation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 6041-9. PMID 12853422 |
0.362 |
|
| 2003 |
Mangoni ME, Couette B, Bourinet E, Platzer J, Reimer D, Striessnig J, Nargeot J. Functional role of L-type Cav1.3 Ca2+ channels in cardiac pacemaker activity. Proceedings of the National Academy of Sciences of the United States of America. 100: 5543-8. PMID 12700358 DOI: 10.1073/Pnas.0935295100 |
0.514 |
|
| 2003 |
Glueckert R, Wietzorrek G, Kammen-Jolly K, Scholtz A, Stephan K, Striessnig J, Schrott-Fischer A. Role of class D L-type Ca2+ channels for cochlear morphology. Hearing Research. 178: 95-105. PMID 12684182 DOI: 10.1016/S0378-5955(03)00054-6 |
0.418 |
|
| 2003 |
Koschak A, Reimer D, Walter D, Hoda J, Heinzle T, Grabner M, Striessnig J. Cav1.4α1 Subunits Can Form Slowly Inactivating Dihydropyridine-Sensitive L-Type Ca2+ Channels Lacking Ca2+-Dependent Inactivation The Journal of Neuroscience. 23: 6041-6049. DOI: 10.1523/Jneurosci.23-14-06041.2003 |
0.435 |
|
| 2002 |
Tottene A, Fellin T, Pagnutti S, Luvisetto S, Striessnig J, Fletcher C, Pietrobon D. Familial hemiplegic migraine mutations increase Ca(2+) influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons. Proceedings of the National Academy of Sciences of the United States of America. 99: 13284-9. PMID 12235360 DOI: 10.1073/pnas.192242399 |
0.427 |
|
| 2002 |
Hitzl M, Striessnig J, Neuhuber B, Flucher BE. A mutation in the beta interaction domain of the Ca(2+) channel alpha(1C) subunit reduces the affinity of the (+)-[(3)H]isradipine binding site. Febs Letters. 524: 188-92. PMID 12135765 DOI: 10.1016/S0014-5793(02)03054-5 |
0.457 |
|
| 2002 |
Day M, Olson PA, Platzer J, Striessnig J, Surmeier DJ. Stimulation of 5-HT(2) receptors in prefrontal pyramidal neurons inhibits Ca(v)1.2 L type Ca(2+) currents via a PLCbeta/IP3/calcineurin signaling cascade. Journal of Neurophysiology. 87: 2490-504. PMID 11976386 DOI: 10.1152/Jn.00843.2001 |
0.311 |
|
| 2002 |
Engel J, Michna M, Platzer J, Striessnig J. Calcium channels in mouse hair cells: function, properties and pharmacology. Advances in Oto-Rhino-Laryngology. 59: 35-41. PMID 11885659 DOI: 10.1159/000059243 |
0.49 |
|
| 2002 |
Wappl E, Koschak A, Poteser M, Sinnegger MJ, Walter D, Eberhart A, Groschner K, Glossmann H, Kraus RL, Grabner M, Striessnig J. Functional consequences of P/Q-type Ca2+ channel Cav2.1 missense mutations associated with episodic ataxia type 2 and progressive ataxia. The Journal of Biological Chemistry. 277: 6960-6. PMID 11742003 DOI: 10.1074/Jbc.M110948200 |
0.674 |
|
| 2001 |
Barg S, Ma X, Eliasson L, Galvanovskis J, Göpel SO, Obermüller S, Platzer J, Renström E, Trus M, Atlas D, Striessnig J, Rorsman P. Fast exocytosis with few Ca(2+) channels in insulin-secreting mouse pancreatic B cells. Biophysical Journal. 81: 3308-23. PMID 11720994 DOI: 10.1016/S0006-3495(01)75964-4 |
0.542 |
|
| 2001 |
Striessnig J. Targeting voltage-gated Ca2+ channels. Lancet. 357: 1294. PMID 11421217 DOI: 10.1016/S0140-6736(00)04440-8 |
0.508 |
|
| 2001 |
Koschak A, Reimer D, Huber I, Grabner M, Glossmann H, Engel J, Striessnig J. alpha 1D (Cav1.3) subunits can form l-type Ca2+ channels activating at negative voltages. The Journal of Biological Chemistry. 276: 22100-6. PMID 11285265 DOI: 10.1074/Jbc.M101469200 |
0.662 |
|
| 2001 |
Wappl E, Mitterdorfer J, Glossmann H, Striessnig J. Mechanism of dihydropyridine interaction with critical binding residues of L-type Ca2+ channel alpha 1 subunits. The Journal of Biological Chemistry. 276: 12730-5. PMID 11278630 DOI: 10.1074/Jbc.M010164200 |
0.679 |
|
| 2001 |
Liu X, Rusch NJ, Striessnig J, Sarna SK. Down-regulation of L-type calcium channels in inflamed circular smooth muscle cells of the canine colon. Gastroenterology. 120: 480-9. PMID 11159888 DOI: 10.1053/gast.2001.21167 |
0.479 |
|
| 2000 |
Seisenberger C, Specht V, Welling A, Platzer J, Pfeifer A, Kühbandner S, Striessnig J, Klugbauer N, Feil R, Hofmann F. Functional embryonic cardiomyocytes after disruption of the L-type alpha1C (Cav1.2) calcium channel gene in the mouse. The Journal of Biological Chemistry. 275: 39193-9. PMID 10973973 DOI: 10.1074/jbc.M006467200 |
0.395 |
|
| 2000 |
Platzer J, Engel J, Schrott-Fischer A, Stephan K, Bova S, Chen H, Zheng H, Striessnig J. Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels. Cell. 102: 89-97. PMID 10929716 DOI: 10.1016/S0092-8674(00)00013-1 |
0.444 |
|
| 2000 |
Matthes J, Huber I, Haaf O, Antepohl W, Striessnig J, Herzig S. Pharmacodynamic interaction between mibefradil and other calcium channel blockers. Naunyn-Schmiedeberg's Archives of Pharmacology. 361: 578-83. PMID 10882031 DOI: 10.1007/S002100000239 |
0.491 |
|
| 2000 |
Eller P, Berjukov S, Wanner S, Huber I, Hering S, Knaus HG, Toth G, Kimball SD, Striessnig J. High affinity interaction of mibefradil with voltage-gated calcium and sodium channels. British Journal of Pharmacology. 130: 669-77. PMID 10821797 DOI: 10.1038/Sj.Bjp.0703352 |
0.603 |
|
| 2000 |
Huber I, Wappl E, Herzog A, Mitterdorfer J, Glossmann H, Langer T, Striessnig J. Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain. The Biochemical Journal. 347: 829-36. PMID 10769189 DOI: 10.1042/Bj3470829 |
0.709 |
|
| 2000 |
Kraus RL, Sinnegger MJ, Koschak A, Glossmann H, Stenirri S, Carrera P, Striessnig J. Three new familial hemiplegic migraine mutants affect P/Q-type Ca(2+) channel kinetics. The Journal of Biological Chemistry. 275: 9239-43. PMID 10734061 DOI: 10.1074/Jbc.275.13.9239 |
0.678 |
|
| 2000 |
Reimer D, Huber IG, Garcia ML, Haase H, Striessnig J. beta subunit heterogeneity of L-type Ca(2+) channels in smooth muscle tissues. Febs Letters. 467: 65-9. PMID 10664458 DOI: 10.1016/S0014-5793(00)01124-8 |
0.44 |
|
| 2000 |
Liu X, Striessnig J, Rusch NJ, Sarna SK. Inflammation impairs the expression and function of L-type CA2+ channels in colonic circular smooth muscle cells from HLA-B27 rat Gastroenterology. 118: A149. DOI: 10.1016/S0016-5085(00)82672-4 |
0.334 |
|
| 1999 |
Striessnig J. Pharmacology, structure and function of cardiac L-type Ca(2+) channels. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 9: 242-69. PMID 10575201 DOI: 10.1159/000016320 |
0.555 |
|
| 1999 |
Gerster U, Neuhuber B, Groschner K, Striessnig J, Flucher BE. Current modulation and membrane targeting of the calcium channel alpha1C subunit are independent functions of the beta subunit. The Journal of Physiology. 517: 353-68. PMID 10332087 DOI: 10.1111/J.1469-7793.1999.0353T.X |
0.468 |
|
| 1999 |
Leitner B, Lovisetti-Scamihorn P, Heilmann J, Striessnig J, Blakely RD, Eiden LE, Winkler H. Subcellular localization of chromogranins, calcium channels, amine carriers, and proteins of the exocytotic machinery in bovine splenic nerve. Journal of Neurochemistry. 72: 1110-6. PMID 10037482 DOI: 10.1046/J.1471-4159.1999.0721110.X |
0.385 |
|
| 1998 |
Kraus RL, Hering S, Grabner M, Ostler D, Striessnig J. Molecular mechanism of diltiazem interaction with L-type Ca2+ channels. The Journal of Biological Chemistry. 273: 27205-12. PMID 9765241 DOI: 10.1074/Jbc.273.42.27205 |
0.533 |
|
| 1998 |
Mitterdorfer J, Grabner M, Kraus RL, Hering S, Prinz H, Glossmann H, Striessnig J. Molecular basis of drug interaction with L-type Ca2+ channels. Journal of Bioenergetics and Biomembranes. 30: 319-34. PMID 9758329 DOI: 10.1023/A:1021933504909 |
0.706 |
|
| 1998 |
Striessnig J, Grabner M, Mitterdorfer J, Hering S, Sinnegger MJ, Glossmann H. Structural basis of drug binding to L Ca2+ channels. Trends in Pharmacological Sciences. 19: 108-15. PMID 9584627 DOI: 10.1016/S0165-6147(98)01171-7 |
0.729 |
|
| 1998 |
Kraus RL, Sinnegger MJ, Glossmann H, Hering S, Striessnig J. Familial hemiplegic migraine mutations change alpha1A Ca2+ channel kinetics. The Journal of Biological Chemistry. 273: 5586-90. PMID 9488686 DOI: 10.1074/Jbc.273.10.5586 |
0.657 |
|
| 1997 |
Hering S, Aczél S, Kraus RL, Berjukow S, Striessnig J, Timin EN. Molecular mechanism of use-dependent calcium channel block by phenylalkylamines: role of inactivation. Proceedings of the National Academy of Sciences of the United States of America. 94: 13323-8. PMID 9371844 DOI: 10.1073/Pnas.94.24.13323 |
0.573 |
|
| 1997 |
Sinnegger MJ, Wang Z, Grabner M, Hering S, Striessnig J, Glossmann H, Mitterdorfer J. Nine L-type amino acid residues confer full 1,4-dihydropyridine sensitivity to the neuronal calcium channel alpha1A subunit. Role of L-type Met1188. The Journal of Biological Chemistry. 272: 27686-93. PMID 9346909 DOI: 10.1074/Jbc.272.44.27686 |
0.696 |
|
| 1997 |
Pichler M, Cassidy TN, Reimer D, Haase H, Kraus R, Ostler D, Striessnig J. Beta subunit heterogeneity in neuronal L-type Ca2+ channels. The Journal of Biological Chemistry. 272: 13877-82. PMID 9153247 DOI: 10.1074/Jbc.272.21.13877 |
0.411 |
|
| 1997 |
Safayhi H, Haase H, Kramer U, Bihlmayer A, Roenfeldt M, Ammon HP, Froschmayr M, Cassidy TN, Morano I, Ahlijanian MK, Striessnig J. L-type calcium channels in insulin-secreting cells: biochemical characterization and phosphorylation in RINm5F cells. Molecular Endocrinology (Baltimore, Md.). 11: 619-29. PMID 9139805 DOI: 10.1210/Mend.11.5.9922 |
0.731 |
|
| 1997 |
Moebius FF, Striessnig J, Glossmann H. The mysteries of sigma receptors: new family members reveal a role in cholesterol synthesis. Trends in Pharmacological Sciences. 18: 67-70. PMID 9133773 DOI: 10.1016/S0165-6147(96)01037-1 |
0.491 |
|
| 1997 |
Brauns T, Prinz H, Kimball SD, Haugland RP, Striessnig J, Glossmann H. L-type calcium channels: binding domains for dihydropyridines and benzothiazepines are located in close proximity to each other. Biochemistry. 36: 3625-31. PMID 9132014 DOI: 10.1021/Bi9613584 |
0.64 |
|
| 1997 |
Hinterdorfer P, Gruber HJ, Striessnig J, Glossmann H, Schindler H. Analysis of membrane protein self-association in lipid systems by fluorescence particle counting: application to the dihydropyridine receptor. Biochemistry. 36: 4497-504. PMID 9109657 DOI: 10.1021/Bi962009C |
0.498 |
|
| 1996 |
Mitterdorfer J, Wang Z, Sinnegger MJ, Hering S, Striessnig J, Grabner M, Glossmann H. Two amino acid residues in the IIIS5 segment of L-type calcium channels differentially contribute to 1,4-dihydropyridine sensitivity. The Journal of Biological Chemistry. 271: 30330-5. PMID 8939992 DOI: 10.1074/Jbc.271.48.30330 |
0.651 |
|
| 1996 |
Berjukov S, Aczel S, Beyer B, Kimball SD, Dichtl M, Hering S, Striessnig J. Extra- and intracellular action of quaternary devapamil on muscle L-type Ca(2+)-channels. British Journal of Pharmacology. 119: 1197-202. PMID 8937723 DOI: 10.1111/J.1476-5381.1996.Tb16022.X |
0.557 |
|
| 1996 |
Pichler M, Wang Z, Grabner-Weiss C, Reimer D, Hering S, Grabner M, Glossmann H, Striessnig J. Block of P/Q-type calcium channels by therapeutic concentrations of aminoglycoside antibiotics. Biochemistry. 35: 14659-64. PMID 8931565 DOI: 10.1021/Bi961657T |
0.675 |
|
| 1996 |
Hering S, Aczél S, Grabner M, Döring F, Berjukow S, Mitterdorfer J, Sinnegger MJ, Striessnig J, Degtiar VE, Wang Z, Glossmann H. Transfer of high sensitivity for benzothiazepines from L-type to class A (BI) calcium channels. The Journal of Biological Chemistry. 271: 24471-5. PMID 8798706 DOI: 10.1074/Jbc.271.40.24471 |
0.675 |
|
| 1996 |
Mitterdorfer J, Froschmayr M, Grabner M, Moebius FF, Glossmann H, Striessnig J. Identification of PK-A phosphorylation sites in the carboxyl terminus of L-type calcium channel alpha 1 subunits. Biochemistry. 35: 9400-6. PMID 8755718 DOI: 10.1021/Bi960683O |
0.639 |
|
| 1996 |
Hanner M, Moebius FF, Flandorfer A, Knaus HG, Striessnig J, Kempner E, Glossmann H. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proceedings of the National Academy of Sciences of the United States of America. 93: 8072-7. PMID 8755605 DOI: 10.1073/Pnas.93.15.8072 |
0.567 |
|
| 1996 |
Kraus R, Reichl B, Kimball SD, Grabner M, Murphy BJ, Catterall WA, Striessnig J. Identification of benz(othi)azepine-binding regions within L-type calcium channel alpha1 subunits. The Journal of Biological Chemistry. 271: 20113-8. PMID 8702733 DOI: 10.1074/jbc.271.33.20113 |
0.633 |
|
| 1996 |
Döring F, Degtiar VE, Grabner M, Striessnig J, Hering S, Glossman H. Transfer of L-type calcium channel IVS6 segment increases phenylalkylamine sensitivity of alpha1A. The Journal of Biological Chemistry. 271: 11745-9. PMID 8662622 DOI: 10.1074/Jbc.271.20.11745 |
0.466 |
|
| 1996 |
Boer R, Dichtl M, Borchers C, Ulrich WR, Marecek JF, Prestwich GD, Glossmann H, Striessnig J. Reversible labeling of a chemosensitizer binding domain of p-glycoprotein with a novel 1,4-dihydropyridine drug transport inhibitor. Biochemistry. 35: 1387-96. PMID 8634268 DOI: 10.1021/Bi951912U |
0.551 |
|
| 1996 |
Thévenod F, Hildebrandt JP, Striessnig J, de Jonge HR, Schulz I. Chloride and potassium conductances of mouse pancreatic zymogen granules are inversely regulated by a approximately 80-kDa mdr1a gene product. The Journal of Biological Chemistry. 271: 3300-5. PMID 8621734 DOI: 10.1074/Jbc.271.6.3300 |
0.314 |
|
| 1996 |
Grabner M, Wang Z, Hering S, Striessnig J, Glossmann H. Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels. Neuron. 16: 207-18. PMID 8562085 DOI: 10.1016/S0896-6273(00)80037-9 |
0.701 |
|
| 1996 |
Thévenod F, Striessnig J, Haase W, Anderie I, Hildebrandt JP, De Jonge HR, Schulz I. Functional relationship between a 65-kD mdr1 P-glycoprotein and ATP-activated chloride conductance in pancreatic zymogen granule membranes Cellular Physiology and Biochemistry. 6: 91-104. DOI: 10.1159/000154798 |
0.334 |
|
| 1995 |
Dietl P, Haller T, Wirleitner B, Völkl H, Friedrich F, Striessnig J. Activation of L-type Ca2+ channels after purinoceptor stimulation by ATP in an alveolar epithelial cell (L2). The American Journal of Physiology. 269: L873-83. PMID 8572250 |
0.339 |
|
| 1995 |
Brauns T, Cai ZW, Kimball SD, Kang KC, Haugland RP, Berger W, Berjukov S, Hering S, Glossmann H, Striessnig J. Benzothiazepine binding domain of purified L-type calcium channels: direct labeling using a novel fluorescent diltiazem analogue. Biochemistry. 34: 3461-9. PMID 7880840 |
0.635 |
|
| 1995 |
Hanner M, Moebius FF, Weber F, Grabner M, Striessnig J, Glossmann H. Phenylalkylamine Ca2+ antagonist binding protein. Molecular cloning, tissue distribution, and heterologous expression. The Journal of Biological Chemistry. 270: 7551-7. PMID 7706302 DOI: 10.1074/Jbc.270.13.7551 |
0.583 |
|
| 1995 |
Mitterdorfer J, Sinnegger MJ, Grabner M, Striessnig J, Glossmann H. Coordination of Ca2+ by the pore region glutamates is essential for high-affinity dihydropyridine binding to the cardiac Ca2+ channel alpha 1 subunit. Biochemistry. 34: 9350-5. PMID 7626604 DOI: 10.1021/Bi00029A010 |
0.64 |
|
| 1994 |
Grabner M, Bachmann A, Rosenthal F, Striessnig J, Schultz C, Tautz D, Glossmann H. Insect calcium channels. Molecular cloning of an alpha 1-subunit from housefly (Musca domestica) muscle. Febs Letters. 339: 189-94. PMID 8313972 DOI: 10.1016/0014-5793(94)80413-3 |
0.643 |
|
| 1994 |
Moebius FF, Hanner M, Knaus HG, Weber F, Striessnig J, Glossmann H. Purification and amino-terminal sequencing of the high affinity phenylalkylamine Ca2+ antagonist binding protein from guinea pig liver endoplasmic reticulum. The Journal of Biological Chemistry. 269: 29314-20. PMID 7961902 |
0.535 |
|
| 1994 |
Mitterdorfer J, Froschmayr M, Grabner M, Striessnig J, Glossmann H. Calcium channels: the beta-subunit increases the affinity of dihydropyridine and Ca2+ binding sites of the alpha 1-subunit. Febs Letters. 352: 141-5. PMID 7925963 DOI: 10.1016/0014-5793(94)00938-4 |
0.671 |
|
| 1994 |
Berger W, Prinz H, Striessnig J, Kang HC, Haugland R, Glossmann H. Complex molecular mechanism for dihydropyridine binding to L-type Ca(2+)-channels as revealed by fluorescence resonance energy transfer. Biochemistry. 33: 11875-83. PMID 7918406 DOI: 10.1021/Bi00205A025 |
0.594 |
|
| 1993 |
Moebius FF, Burrows GG, Striessnig J, Glossmann H. Biochemical characterization of a 22-kDa high affinity antiischemic drug-binding polypeptide in the endoplasmic reticulum of guinea pig liver: potential common target for antiischemic drug action. Molecular Pharmacology. 43: 139-48. PMID 8429820 |
0.526 |
|
| 1993 |
Hering S, Savchenko A, Strübing C, Lakitsch M, Striessnig J. Extracellular localization of the benzothiazepine binding domain of L-type Ca2+ channels. Molecular Pharmacology. 43: 820-6. PMID 8388993 |
0.486 |
|
| 1993 |
Lakitsch M, Knaus HG, Topar G, Romanin C, Boer R, Flockerzi D, Striessnig J, Schindler H, Hoeltje HD, Glossmann H. Heterogeneity of L-type calcium channel alpha 1 subunits: stereoselective discrimination of different populations by the novel 1,4-dihydropyridine B 874-67. Molecular Pharmacology. 43: 293-301. PMID 8381514 |
0.65 |
|
| 1993 |
Moebius FF, Burrows GG, Hanner M, Schmid E, Striessnig J, Glossmann H. Identification of a 27-kDa high affinity phenylalkylamine-binding polypeptide as the sigma 1 binding site by photoaffinity labeling and ligand-directed antibodies. Molecular Pharmacology. 44: 966-71. PMID 8246920 |
0.522 |
|
| 1993 |
Eismann E, Bönigk W, Kaupp B, Macdonald RL, Angelotti TP, Paulmichl M, Gschwentner M, Wöll E, Schmarda A, Ritter M, Kanin G, Ellemunter H, Waitz W, Deetjen P, Carroll TP, ... ... Striessnig J, et al. Subject Index, Vol. 3, 1993 Cellular Physiology and Biochemistry. 3: 401-402. DOI: 10.1159/000154702 |
0.457 |
|
| 1993 |
Striessnig J, Berger W, Glossmann H. Molecular properties of voltage-dependent ca2+ channels in excitable tissues Cellular Physiology and Biochemistry. 3: 295-317. DOI: 10.1159/000154695 |
0.719 |
|
| 1993 |
Eismann E, Bönigk W, Kaupp B, Macdonald RL, Angelotti TP, Paulmichl M, Gschwentner M, Wöll E, Schmarda A, Ritter M, Kanin G, Ellemunter H, Waitz W, Deetjen P, Carroll TP, ... ... Striessnig J, et al. Contents, Vol. 3, 1993 Cellular Physiology and Biochemistry. 3. DOI: 10.1159/000154687 |
0.452 |
|
| 1992 |
Florio V, Striessnig J, Catterall WA. Purification and reconstitution of skeletal muscle calcium channels. Methods in Enzymology. 207: 529-46. PMID 1382201 DOI: 10.1016/0076-6879(92)07037-O |
0.647 |
|
| 1992 |
Catterall WA, Striessnig J. Receptor sites for Ca2+ channel antagonists. Trends in Pharmacological Sciences. 13: 256-62. PMID 1321525 DOI: 10.1016/0165-6147(92)90079-L |
0.661 |
|
| 1992 |
Knaus HG, Striessnig J, Hering S, Marrer S, Schwenner E, Höltje HD, Glossmann H. [35S]sadopine, a novel high affinity, high specific activity, L-type Ca2+ channel probe: characterization of two equipotent diastereomers with opposite allosteric properties. Molecular Pharmacology. 41: 298-307. PMID 1311409 |
0.7 |
|
| 1992 |
Striessnig J, Glossmann H. L-type calcium channels and calcium channel ligands Pharmacochemistry Library. 18: 333-343. DOI: 10.1016/B978-0-444-88931-7.50024-4 |
0.699 |
|
| 1991 |
Glossmann H, Zech C, Striessnig J, Staudinger R, Hall L, Greenberg R, Armah BI. Very high affinity interaction of DPI 201-106 and BDF 8784 enantiomers with the phenylalkylamine-sensitive Ca2(+)-channel in Drosophila head membranes. British Journal of Pharmacology. 102: 446-52. PMID 1849770 DOI: 10.1111/J.1476-5381.1991.Tb12193.X |
0.718 |
|
| 1991 |
Grabner M, Friedrich K, Knaus HG, Striessnig J, Scheffauer F, Staudinger R, Koch WJ, Schwartz A, Glossmann H. Calcium channels from Cyprinus carpio skeletal muscle. Proceedings of the National Academy of Sciences of the United States of America. 88: 727-31. PMID 1846962 DOI: 10.1073/Pnas.88.3.727 |
0.653 |
|
| 1991 |
Striessnig J, Murphy BJ, Catterall WA. Dihydropyridine receptor of L-type Ca2+ channels: identification of binding domains for [3H](+)-PN200-110 and [3H]azidopine within the alpha 1 subunit. Proceedings of the National Academy of Sciences of the United States of America. 88: 10769-73. PMID 1660150 DOI: 10.1073/Pnas.88.23.10769 |
0.618 |
|
| 1991 |
Ahlijanian MK, Striessnig J, Catterall WA. Phosphorylation of an alpha 1-like subunit of an omega-conotoxin-sensitive brain calcium channel by cAMP-dependent protein kinase and protein kinase. The Journal of Biological Chemistry. 266: 20192-7. PMID 1657916 |
0.768 |
|
| 1991 |
Nakayama H, Taki M, Striessnig J, Glossmann H, Catterall WA, Kanaoka Y. Identification of 1,4-dihydropyridine binding regions within the alpha 1 subunit of skeletal muscle Ca2+ channels by photoaffinity labeling with diazipine. Proceedings of the National Academy of Sciences of the United States of America. 88: 9203-7. PMID 1656465 |
0.703 |
|
| 1991 |
Haase H, Striessnig J, Holtzhauer M, Vetter R, Glossmann H. A rapid procedure for the purification of cardiac 1,4-dihydropyridine receptors from porcine heart. European Journal of Pharmacology. 207: 51-9. PMID 1655494 DOI: 10.1016/S0922-4106(05)80037-9 |
0.641 |
|
| 1991 |
Striessnig J, Glossmann H. [14] - Purification of L-Type Calcium Channel Drug Receptors Methods in Neurosciences. 4: 210-229. DOI: 10.1016/B978-0-12-185257-3.50019-7 |
0.654 |
|
| 1990 |
Striessnig J, Glossmann H, Catterall WA. Identification of a phenylalkylamine binding region within the alpha 1 subunit of skeletal muscle Ca2+ channels. Proceedings of the National Academy of Sciences of the United States of America. 87: 9108-12. PMID 2174553 DOI: 10.1073/Pnas.87.23.9108 |
0.754 |
|
| 1990 |
Glossmann H, Striessnig J. Molecular properties of calcium channels. Reviews of Physiology, Biochemistry and Pharmacology. 114: 1-105. PMID 2155469 DOI: 10.1007/Bfb0031018 |
0.654 |
|
| 1990 |
Striessnig J, Scheffauer F, Mitterdorfer J, Schirmer M, Glossmann H. Identification of the benzothiazepine-binding polypeptide of skeletal muscle calcium channels with (+)-cis-azidodiltiazem and anti-ligand antibodies. The Journal of Biological Chemistry. 265: 363-70. PMID 2152924 |
0.619 |
|
| 1989 |
Grassegger A, Striessnig J, Weiler M, Knaus HG, Glossmann H. [3H]HOE166 defines a novel calcium antagonist drug receptor--distinct from the 1,4 dihydropyridine binding domain. Naunyn-Schmiedeberg's Archives of Pharmacology. 340: 752-9. PMID 2561307 DOI: 10.1007/Bf00169685 |
0.695 |
|
| 1989 |
Glossmann H, Striessnig J, Knaus HG, Müller J, Grassegger A, Höltje HD, Marrer S, Hymel L, Schindler HG. Structure of calcium channels. Annals of the New York Academy of Sciences. 560: 198-214. PMID 2545133 DOI: 10.1111/J.1749-6632.1989.Tb24098.X |
0.654 |
|
| 1989 |
Greenberg RM, Striessnig J, Koza A, Devay P, Glossmann H, Hall LM. Native and detergent-solubilized membrane extracts from Drosophila heads contain binding sites for phenylalkylamine calcium channel blockers Insect Biochemistry. 19: 309-322. DOI: 10.1016/0020-1790(89)90077-2 |
0.6 |
|
| 1989 |
Hymel L, Schindler H, Inui M, Fleischer S, Striessnig J, Glossmann H. A molecular model of excitation - contraction coupling at the skeletal muscle triad junction via coassociated oligomeric calcium channels Annals of the New York Academy of Sciences. 560: 185-188. |
0.584 |
|
| 1988 |
Glossmann H, Striessnig J. Calcium channels. Vitamins and Hormones. 44: 155-328. PMID 2853487 |
0.625 |
|
| 1988 |
Striessnig J, Knaus HG, Glossmann H. Photoaffinity-labelling of the calcium-channel-associated 1,4-dihydropyridine and phenylalkylamine receptor in guinea-pig hippocampus. A 195 kDa polypeptide carries both drug receptors and has similarities to the alpha 1 subunit of the purified skeletal-muscle calcium channel. The Biochemical Journal. 253: 39-47. PMID 2844171 DOI: 10.1042/Bj2530039 |
0.676 |
|
| 1988 |
Striessnig J, Meusburger E, Grabner M, Knaus HG, Glossmann H, Kaiser J, Schölkens B, Becker R, Linz W, Henning R. Evidence for a distinct Ca2+ antagonist receptor for the novel benzothiazinone compound HOE 166. Naunyn-Schmiedeberg's Archives of Pharmacology. 337: 331-40. PMID 2839780 DOI: 10.1007/Bf00168847 |
0.655 |
|
| 1988 |
Hymel L, Striessnig J, Glossmann H, Schindler H. Purified skeletal muscle 1,4-dihydropyridine receptor forms phosphorylation-dependent oligomeric calcium channels in planar bilayers. Proceedings of the National Academy of Sciences of the United States of America. 85: 4290-4. PMID 2454467 DOI: 10.1073/Pnas.85.12.4290 |
0.723 |
|
| 1988 |
Glossmann H, Striessnig J, Hymel L, Schindler H. Purification and reconstitution of calcium channel drug-receptor sites. Annals of the New York Academy of Sciences. 522: 150-61. PMID 2454049 DOI: 10.1111/J.1749-6632.1988.Tb33351.X |
0.663 |
|
| 1988 |
Striessnig J, Glossmann H. Characterization of the drug receptors of the purified skeletal muscle calcium channel. Progress in Clinical and Biological Research. 252: 35-40. PMID 2450374 |
0.612 |
|
| 1988 |
Glossmann H, Striessnig J, Knaus H, Müller J, Zernig G, Moshammer T, Grassegger A. Radiochemicals in the study of receptors International Journal of Radiation Applications and Instrumentation. Part a. Applied Radiation and Isotopes. 39: 505. DOI: 10.1016/0883-2889(88)90201-8 |
0.656 |
|
| 1988 |
Glossmann H, Striessnig J. Structure and pharmacology of voltage-dependent calcium channels Isi Atlas of Science: Pharmacology. 2: 202-210. |
0.621 |
|
| 1987 |
Knaus HG, Striessnig J, Koza A, Glossmann H. Neurotoxic aminoglycoside antibiotics are potent inhibitors of [125I]-Omega-Conotoxin GVIA binding to guinea-pig cerebral cortex membranes. Naunyn-Schmiedeberg's Archives of Pharmacology. 336: 583-6. PMID 2830547 DOI: 10.1007/Bf00169318 |
0.662 |
|
| 1987 |
Glossmann H, Striessnig J, Hymel L, Schindler H. Purified L-type calcium channels: only one single polypeptide (alpha 1-subunit) carries the drug receptor domains and is regulated by protein kinases. Biomedica Biochimica Acta. 46: S351-6. PMID 2449181 |
0.639 |
|
| 1987 |
Vaghy PL, Striessnig J, Miwa K, Knaus HG, Itagaki K, McKenna E, Glossmann H, Schwartz A. Identification of a novel 1,4-dihydropyridine- and phenylalkylamine-binding polypeptide in calcium channel preparations. The Journal of Biological Chemistry. 262: 14337-42. PMID 2443504 |
0.6 |
|
| 1987 |
Glossmann H, Striessnig J, Ferry DR, Goll A, Moosburger K, Schirmer M. Interaction between calcium channel ligands and calcium channels. Circulation Research. 61: I30-6. PMID 2443273 |
0.647 |
|
| 1987 |
Striessnig J, Knaus HG, Grabner M, Moosburger K, Seitz W, Lietz H, Glossmann H. Photoaffinity labelling of the phenylalkylamine receptor of the skeletal muscle transverse-tubule calcium channel. Febs Letters. 212: 247-53. PMID 2434359 DOI: 10.1016/0014-5793(87)81354-6 |
0.696 |
|
| 1987 |
Glossmann H, Ferry DR, Striessnig J, Goll A, Moosburger K. Resolving the structure of the Ca2+ channel by photoaffinity labelling Trends in Pharmacological Sciences. 8: 95-100. DOI: 10.1016/0165-6147(87)90082-4 |
0.712 |
|
| 1986 |
Striessnig J, Moosburger K, Goll A, Ferry DR, Glossmann H. Stereoselective photoaffinity labelling of the purified 1,4-dihydropyridine receptor of the voltage-dependent calcium channel. European Journal of Biochemistry / Febs. 161: 603-9. PMID 2431906 DOI: 10.1111/J.1432-1033.1986.Tb10484.X |
0.643 |
|
| 1986 |
Striessnig J, Goll A, Moosburger K, Glossmann H. Purified calcium channels have three allosterically coupled drug receptors. Febs Letters. 197: 204-10. PMID 2419161 DOI: 10.1016/0014-5793(86)80327-1 |
0.701 |
|
| 1985 |
Striessnig J, Zernig G, Glossmann H. Human red-blood-cell Ca2+-antagonist binding sites. Evidence for an unusual receptor coupled to the nucleoside transporter. European Journal of Biochemistry / Febs. 150: 67-77. PMID 2990927 DOI: 10.1111/J.1432-1033.1985.Tb08989.X |
0.614 |
|
| 1985 |
Striessnig J, Zernig G, Glossmann H. Ca2+ antagonist receptor sites on human red blood cell membranes. European Journal of Pharmacology. 108: 329-30. PMID 2985404 DOI: 10.1016/0014-2999(85)90460-1 |
0.569 |
|
| 1985 |
Glossmann H, Ferry DR, Goll A, Striessnig J, Zernig G. Calcium channels and calcium channel drugs: recent biochemical and biophysical findings. Arzneimittel-Forschung. 35: 1917-35. PMID 2420337 |
0.651 |
|
| 1985 |
Glossmann H, Ferry DR, Goll A, Striessnig J, Schober M. Calcium channels: basic properties as revealed by radioligand binding studies. Journal of Cardiovascular Pharmacology. 7: S20-30. PMID 2414589 |
0.656 |
|
| 1984 |
Goll A, Ferry DR, Striessnig J, Schober M, Glossmann H. (-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle. Febs Letters. 176: 371-7. PMID 6092142 DOI: 10.1016/0014-5793(84)81199-0 |
0.661 |
|
| Show low-probability matches. |